Adverse Drug Events Reporting News

  • Anti-IL-1 Drug May Be Better in RA With Type 2 Diabetes Blocking the IL-1 pathway with anakinra appeared to be more effective in a small study of patients who had rheumatoid arthritis and type 2 diabetes than in those with RA alone.
  • Eighty Years On, the Debate Over ECT Continues To its many advocates, ECT is perhaps the most effective treatment in psychiatry. Its critics argue this can come at a substantial cost. Is this disagreement intractable?
 

Adverse Drug Events Reporting Perspective

 

Adverse Drug Events Reporting Journal Articles